Barrett Hodgson Pakistan (Pvt) Ltd is pleased to announce the launch of Dimara™.
Dimara™ is indicated for the treatment of Rheumatoid Arthritis and it act as anti-proliferative and anti- inflammatory agent and helps to improve the quality of life of the patients through retardation of joint destruction and improvement in functional ability of the joints.
Dimara™ is available as 20 mg tablet in pack of 30’s.
By introducing Dimara™ (Leflunomide) Barrett Hodgson provides the ailing community with yet another Effective, Safe, Economical and Quality product.